Effect of Potent P2Y

Chunmei Wang, Guanqi Zhao, Xiao Wang, Shaoping Nie

Open access · hybridAbstract readMeta-AnalysisSystematic Review

In one paragraph

Synthesis in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.5field-weighted citation impact, top 29% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

Cardioprotective properties of the platelet P2YPharmacological reports : PR · 2020
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chunmei WangEmergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-1012-5443

Guanqi ZhaoEmergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID 0000-0001-6057-6069

Xiao WangEmergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Shaoping NieEmergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID 0000-0003-0664-5857

Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies have shown that P2Y METHODS AND

resultsWe performed a systematic review and meta-analysis of randomized controlled trials (RCTs) that were published in electronic databases of MEDLINE, EMBASE, Cochrane Central Register of Clinical Trials, and ClinicalTrials.gov before June 20, 2018. We compared the effect of prasugrel and ticagrelor with clopidogrel on outcomes of ventricular tachycardia (VT), ventricular fibrillation (VF), heart failure (HF), and cardiogenic shock (CS). Data were combined using both the fixed-effects models and the random-effects models, and the heterogeneity was assessed with the

conclusionsThis meta-analysis of RCTs shows that, compared with clopidogrel, novel oral P2Y

Indexed as

Arrhythmias, CardiacClinical Trials as TopicCoronary Artery DiseaseHumansPurinergic P2Y Receptor AntagonistsRandomized Controlled Trials as TopicPurinergic P2Y Receptor Antagonists

Identifiers

PMID30648108

DOI10.1155/2018/8572740

PMCPMC6311824

OpenAlexW2904529981

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.